Filing Details
- Accession Number:
- 0001567619-21-004471
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-18 19:26:58
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-18 19:26:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403694 | L. Bruce Claflin | C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-16 | 5,902 | $85.00 | 6,206 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-02-16 | 1,125 | $160.28 | 7,331 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-16 | 6,745 | $536.89 | 586 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-16 | 586 | $537.19 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-02-16 | 5,902 | $0.00 | 5,902 | $85.00 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-02-16 | 1,125 | $0.00 | 1,125 | $160.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-05-03 | No | 4 | M | Direct | |
| 1,921 | 2027-05-02 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average price of the shares sold ranging from a low of $536.13 to a high of $537.125 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $537.15 to a high of $537.23 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018.
- Not applicable.
Billionaire Hedge Funds
